Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC raised its position in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 28.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 355,750 shares of the company’s stock after acquiring an additional 78,835 shares during the period. TimesSquare Capital Management LLC’s holdings in Addus HomeCare were worth $44,593,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Janney Montgomery Scott LLC boosted its stake in Addus HomeCare by 0.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock valued at $1,340,000 after acquiring an additional 91 shares in the last quarter. New York State Teachers Retirement System boosted its stake in Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after acquiring an additional 100 shares in the last quarter. Equitable Trust Co. boosted its stake in Addus HomeCare by 2.2% in the third quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after acquiring an additional 106 shares in the last quarter. Royce & Associates LP boosted its stake in Addus HomeCare by 1.2% in the third quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock valued at $1,187,000 after acquiring an additional 109 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in Addus HomeCare by 11.5% in the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after acquiring an additional 121 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on ADUS shares. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target for the company. Finally, Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Buy” and a consensus target price of $134.22.

Get Our Latest Report on Addus HomeCare

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock worth $4,930,750 over the last three months. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $113.64 on Wednesday. The company has a market capitalization of $2.06 billion, a PE ratio of 26.00, a P/E/G ratio of 1.55 and a beta of 1.00. The company has a fifty day moving average of $125.70 and a 200 day moving average of $127.01. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.72.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.